{
  "image_filename": "figure_p1_det_0_027.png",
  "image_path": "Treanor_et_al.__2011_/extracted/figures/figure_p1_det_0_027.png",
  "image_type": "Figure",
  "page_number": 1,
  "block_id": "det_0_027",
  "claim_id": "claim_002",
  "claim": "Cell- and egg-based flu vaccines have the potential to develop mutations during production, which may reduce their effectiveness.",
  "supports_claim": false,
  "explanation": "A partial page showing the introduction of a clinical document. The visible text describes that embryonated hen\u2019s eggs have been used for influenza vaccine production and notes drawbacks such as the need for specialized facilities, limited scalability in emergencies, and vulnerability to the same virus subtypes. does not support the claim because the text does not mention the development of mutations during egg- or cell-based vaccine production nor any impact on vaccine effectiveness. Note: The image is limited to introductory text and does not include any data or statements about mutations arising during vaccine manufacturing.",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "A partial page showing the introduction of a clinical document. The visible text describes that embryonated hen\u2019s eggs have been used for influenza vaccine production and notes drawbacks such as the need for specialized facilities, limited scalability in emergencies, and vulnerability to the same virus subtypes.",
    "evidence_found": null,
    "reasoning": "does not support the claim because the text does not mention the development of mutations during egg- or cell-based vaccine production nor any impact on vaccine effectiveness.",
    "confidence_notes": "The image is limited to introductory text and does not include any data or statements about mutations arising during vaccine manufacturing."
  }
}